Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
The goal of this clinical trial is to examine perceptions of virtual human communicators and cancer research recruitment messages. This study will also examine how different informed consent approaches influence decisions to participate in research.
Interventions
BEHAVIORALEducational Cancer Intervention
Participants will view informed consent messaging presented in different formats
OTHERICF Text Version 1
Receive a text-based informed consent form
OTHERICF Text Version 2
Receive an adapted text-based informed consent form
OTHERICF Video Version 1
Receive a video-based informed consent form delivered by virtual human #1
OTHERICF Video Version 2
Receive a video-based informed consent form delivered by virtual human #2
OTHERICF Video Version 3
Receive a video-based informed consent form delivered by virtual human #3
OTHERICF Video Version 4
Receive a video-based informed consent form delivered by virtual human #4
OTHERSurvey Administration
Ancillary studies
Sponsors
Mayo Clinic
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Able to speak, read, or understand English sufficiently to provide informed consent * 18 years of age or older * White or Black * Living in the United States
Exclusion criteria
* Unable to speak, read, or understand English sufficiently to provide informed consent * Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-efficacy (Aim 1) | Baseline (immediately following intervention) | Assessed by 3 questions in the study-specific survey. The questions are answered on a scale of 1 (strongly disagree) to 5=strongly agree. Higher scores indicate greater feelings of self-efficacy. |
| Trustworthiness (Aim 2) | Baseline (immediately following intervention) | Assessed by a study-specific survey asking participants to rate the intervention on a scale of 1 (untrustworthy) to 7 (trustworthy). Higher scores indicate greater perception of trustworthiness. |
Countries
United States
Contacts
CONTACTETCH Lab
PRINCIPAL_INVESTIGATORJanice L. Krieger, PhD
Mayo Clinic
Outcome results
None listed